Skip to main content
Figure 1 | BMC Proceedings

Figure 1

From: Golgi engineering of CHO cells by targeted integration of glycosyltransferases leads to the expression of novel Asn-linked oligosaccharide structures at secretory glycoproteins

Figure 1

(A) Non-reducing terminal oligosaccharide motifs attached to N-glycans of specific human glycoproteins (left side). Scheme of model glycoprotein Cetuximab with CH2- and VH-domain N-glycans (right side). (B) NP-HPLC-FLD elution profiles of 2-AB labeled oligosaccharides from VH-domain of Cetuximab after co-expression of the indicated glycosyltransferases.

Back to article page

BMC Proceedings

ISSN: 1753-6561

Contact us